B2M and androgen insensitivity syndrome: Following an AIS cohort of 26–46 months, we found that as a rapid responder of the immune and inflammatory state of the body, the level of peripheral blood β2M in patients with AIS has an important predictive value for the recurrence of AIS, suggesting that β2M is a novel and reliable predictor of recurrent AIS.